L-DABA hydrobromide
Based on 2 publication(s) in Google Scholar
L-DABA (L-2,4-Diaminobutyric acid) hydrobromide is a week GABA transaminase inhibitor with an IC50 of larger than 500 μM; exhibits antitumor activity in vivo and in vitro.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度: 98.0%
- CAS 番号: 73143-97-2
- 分子式: C4H11BrN2O2
- 分子量:199.05
-
保管条件:
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
MedChemExpress(MCE)の使用を引用している文献 L-DABA hydrobromide
MoreEndogenous Metabolite アイソフォーム固有の製品をすべて表示
More
生物活性
IC50: larger than 500 μM (GABA transaminase)[1]
The tumor cells are irreversibly and totally damaged by incubation with 10 mM L-2,4-Diaminobutyric acid for 24 h at 37°C. The cell-destructive effect by L-DABA hydrobromide is probably due to an osmotic lysis induced by the non-saturated intracellular accumulation of L-DABA hydrobromide. The harmful effect of L-DABA hydrobromide could be abolished by concomitant incubation with L-alanine and L-methionine[1]. Kinetic studies indicates that L-DABA hydrobromide is a non-linear, non-competitive inhibitor of GABA transaminase activity. The L-DABA hydrobromide-induced elevation of GABA levels parallels the inhibition of GABA transaminase activity[2]. L-2,4-Diaminobutyric acid, an amino acid analogue, produceS a cytolytic effect with a human glioma cell line, SKMG-1, and normal human fibroblasts. The concentrations of L-DABA hydrobromide necessary to reduce the cell count to 50% of control following a 24-h incubation at 37°C are 12.5 mM for the human fibroblasts and 20 mM for the glioma cell line[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
化学情報
-
CAS 番号 73143-97-2
-
性状 Solid
-
分子量 199.05
-
分子式 C4H11BrN2O2
-
Color White to off-white
-
SMILES
NCC[C@H](N)C(O)=O.[H]Br
-
別名
L-2,4-Diaminobutyric acid hydrobromide
-
Structure Classification
-
Initial Source
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Publications (2)
-
Journal Impact Factor
-
Most Recent
-
Nature
2025 Jul;643(8070):192-200. PMID: 39695227 -
Ann Bot
Integrated LC/MS-MS approaches reveal toxicity differences across seed layers of Cycas angulata. [Abstract]2026 Jun 17:mcag169. PMID: 42308138
溶剤 & 溶解度
H2O : 33.33 mg/mL (167.45 mM; Need ultrasonic)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
純度とドキュメンテーション
-
データシート (272 KB)
-
SDS (394 KB)
- English - EN (394 KB)
- Français - FR (394 KB)
- Deutsch - DE (394 KB)
- Norwegian - NO (394 KB)
- Español - ES (394 KB)
- Swedish - SV (394 KB)
- Italian - IT (394 KB)
- Korean - KR (394 KB)
- Portuguese - PT (394 KB)
-
取扱説明書 (2659 KB)
参考文献
[1]. Ronquist G, et al. Antitumor activity of L-2,4 diaminobuturic acid against mouse fibrosarcoma cells in vitro and in vivo. J Cancer Res Clin Oncol. 1980;96(3):259-68. [Content Brief]
[2]. Beart PM, et al. l-2,4-Diaminobutyric acid and the GABA system. Neurosci Lett. 1977 Jul;5(3-4):193-8. [Content Brief]
[3]. Panasci L, et al. The cytolytic effect of L-2,4 diaminobutyric acid with malignant glioma cells and fibroblasts. Cancer Chemother Pharmacol. 1988;21(2):143-4. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| H2O | 1 mM | 5.0239 mL | 25.1193 mL | 50.2386 mL | 125.5966 mL |
| 5 mM | 1.0048 mL | 5.0239 mL | 10.0477 mL | 25.1193 mL | |
| 10 mM | 0.5024 mL | 2.5119 mL | 5.0239 mL | 12.5597 mL | |
| 15 mM | 0.3349 mL | 1.6746 mL | 3.3492 mL | 8.3731 mL | |
| 20 mM | 0.2512 mL | 1.2560 mL | 2.5119 mL | 6.2798 mL | |
| 25 mM | 0.2010 mL | 1.0048 mL | 2.0095 mL | 5.0239 mL | |
| 30 mM | 0.1675 mL | 0.8373 mL | 1.6746 mL | 4.1866 mL | |
| 40 mM | 0.1256 mL | 0.6280 mL | 1.2560 mL | 3.1399 mL | |
| 50 mM | 0.1005 mL | 0.5024 mL | 1.0048 mL | 2.5119 mL | |
| 60 mM | 0.0837 mL | 0.4187 mL | 0.8373 mL | 2.0933 mL | |
| 80 mM | 0.0628 mL | 0.3140 mL | 0.6280 mL | 1.5700 mL | |
| 100 mM | 0.0502 mL | 0.2512 mL | 0.5024 mL | 1.2560 mL |
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.